1. G protein-specific mechanisms in the serotonin 5-HT 2A receptor regulate psychosis-related effects and memory deficits.
- Author
-
Kossatz E, Diez-Alarcia R, Gaitonde SA, Ramon-Duaso C, Stepniewski TM, Aranda-Garcia D, Muneta-Arrate I, Tepaz E, Saen-Oon S, Soliva R, Shahraki A, Moreira D, Brea J, Loza MI, de la Torre R, Kolb P, Bouvier M, Meana JJ, Robledo P, and Selent J
- Subjects
- Animals, Female, Humans, Male, Mice, Brain metabolism, GTP-Binding Protein alpha Subunits, Gq-G11 metabolism, GTP-Binding Protein alpha Subunits, Gq-G11 genetics, HEK293 Cells, Schizophrenia metabolism, Signal Transduction, Memory Disorders metabolism, Psychotic Disorders metabolism, Psychotic Disorders drug therapy, Receptor, Serotonin, 5-HT2A metabolism, Serotonin metabolism
- Abstract
G protein-coupled receptors (GPCRs) are sophisticated signaling machines able to simultaneously elicit multiple intracellular signaling pathways upon activation. Complete (in)activation of all pathways can be counterproductive for specific therapeutic applications. This is the case for the serotonin 2 A receptor (5-HT
2A R), a prominent target for the treatment of schizophrenia. In this study, we elucidate the complex 5-HT2A R coupling signature in response to different signaling probes, and its physiological consequences by combining computational modeling, in vitro and in vivo experiments with human postmortem brain studies. We show how chemical modification of the endogenous agonist serotonin dramatically impacts the G protein coupling profile of the 5-HT2A R and the associated behavioral responses. Importantly, among these responses, we demonstrate that memory deficits are regulated by Gαq protein activation, whereas psychosis-related behavior is modulated through Gαi1 stimulation. These findings emphasize the complexity of GPCR pharmacology and physiology and open the path to designing improved therapeutics for the treatment of stchizophrenia., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF